Press release
Global Endocrinology Drugs Market to grow at a CAGR of 6.69% during 2016-2020
About Endocrinology DrugsEndocrinology deals with the study of the endocrine system, including the biochemical and physiological functions of the hormones, cells, and tissues of the endocrine glands. Endocrine disorders can be broadly subdivided into three categories: endocrine gland hyposecretion, which causes hormone deficiency, endocrine gland hypersecretion, which causes excess hormone secretion, and tumors in the endocrine gland. The endocrine disorders considered for the present report include diabetes, human growth hormone deficiency, thyroid disorders, and male hypogonadism.
Technavios analysts forecast the global endocrinology drugs market to grow at a CAGR of 6.69% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global endocrinology drugs market for 2015-2020. To calculate the market size, the report considers revenue generated from the sales of branded drugs, generics, and biosimilars used to treat and prevent type 1 and type 2 diabetes, human growth hormone deficiency, hypogonadism, and thyroid gland disorders.
Download Sample Copy of report at http://www.marketresearchreports.biz/sample/sample/711552
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Technavio's report, Global Endocrinology Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
AbbVie Inc.
AstraZeneca PLC
Eli Lilly and Co.
Merck & Co
Novo Nordisk AS
Sanofi SA
Other prominent vendors
Acerus Pharmaceuticals
Acrux DDS
Adocia
terna Zentaris
Akros Pharma
Allergan
Amgen
Antares Pharma
Ascendis Pharma
Astellas Pharma
Baxalta
Bayer HealthCare Pharmaceuticals
BHV Pharma
Biocon
Biodel
Boehringer Ingelheim
ChipScreen Biosciences
Clarus Therapeutics
ConjuChem
Critical Pharmaceuticals
CureDm
CymaBay Therapeutics
Daiichi Sankyo
Dance Biopharm
DiaMedica
Diamyd Therapeutics
Diasome Pharmaceuticals
DiaVacs
Dong-A ST
Eisai
Elcelyx Therapeutics
Endo Pharmaceuticals
Exsulin
Ferring Pharmaceuticals
Gan & Lee Pharmaceuticals
Genentech
Generex
Genexine
Genfit
GSK
HanAll BioPharma
Hanmi Pharmaceutical
Hua Medicine
ILTOO Pharma
Intarcia Therapeutics
InteKrin Therapeutics
Intrexon
Ionis Pharmaceuticals
Ipe
Islet Sciences
Janssen Pharmaceuticals
Japan Tobacco
Juniper Pharmaceuticals
Kadmon Corporation
Kamada
KinDex Pharmaceuticals
Kissei Pharmaceutical
Kotobuki
Lexicon Pharmaceuticals
LG Life Sciences
Ligand Pharmaceuticals
Lipocine
Living Cell Technologies
MacroGenics
MannKind
MedImmune
Melior Pharmaceuticals
Metabolic Solutions Development Company
MetP Pharma
Mitsubishi Tanabe Pharma
Mylan
NGM Biopharmaceuticals
Novartis
NuSirt Biopharma
OPKO Biologics
Oramed Pharmaceuticals
Osiris Therapeutics
Peptron
Perle Biosciences
Pfizer
PhaseBio Pharmaceuticals
Poxel
ProStrakan Group
REGiMMUNE
Repros Therapeutics
Roche
Sanwa Kagaku Kenkyusho
Sirona Biochem
Strongbridge Biopharma
Takeda Pharmaceuticals
TesoRx Pharma
Teva Pharmaceutical
Theracos
Theratechnologies
Toleranzia
Tolerion
Transition Therapeutics
VeroScience
Versartis
vTv Therapeutics
XBiotech
Xeris Pharmaceuticals
XOMA
Market driver
Increase in prevalence of endocrine hormone-related diseases
For a full, detailed list, view our report
Market challenge
Generic erosion
For a full, detailed list, view our report
Market trend
Increase in outsourcing
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
Email: sales@marketresearchreports.biz
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Endocrinology Drugs Market to grow at a CAGR of 6.69% during 2016-2020 here
News-ID: 375640 • Views: β¦
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M β¦
πππ, πππ° πππ«π¬ππ²- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USDΒ 22.32Β Billion by 2024. The valuation is expected to reach USDΒ 47.79Β Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of theβ¦
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi β¦
πππ, πππ° πππ«π¬ππ²- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasingβ¦
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi β¦
πππ, πππ° πππ«π¬ππ²- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. Asβ¦
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh β¦
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of theβ¦
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, β¦
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoringβ¦
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 β¦
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about theβ¦
